Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 153

1.

Genetic Analysis of Substrain Divergence in Non-Obese Diabetic (NOD) Mice.

Simecek P, Churchill GA, Yang H, Rowe LB, Herberg L, Serreze DV, Leiter EH.

G3 (Bethesda). 2015 Mar 3;5(5):771-5. doi: 10.1534/g3.115.017046.

2.

Did the gradual loss of GLUT2 cause a shift to diabetic disorders in the New Zealand obese mouse (NZO/Hl)?

Chankiewitz E, Peschke D, Herberg L, Bazwinsky I, Mühlbauer E, Brömme HJ, Peschke E.

Exp Clin Endocrinol Diabetes. 2006 May;114(5):262-9.

PMID:
16804801
3.

The diabetes-prone NZO/Hl strain. Proliferation capacity of beta cells in hyperinsulinemia and hyperglycemia.

Lange C, Jeruschke K, Herberg L, Leiter EH, Junger E.

Arch Physiol Biochem. 2006 Feb;112(1):49-58.

PMID:
16754203
5.

The diabetes-prone NZO/Hl strain. II. Pancreatic immunopathology.

Junger E, Herberg L, Jeruschke K, Leiter EH.

Lab Invest. 2002 Jul;82(7):843-53.

6.
7.

Apoptosis in the adrenal gland of non-obese diabetic (NOD) mice.

Breidert M, Böttner A, Möller S, Herberg L, Bornstein S.

Exp Clin Endocrinol Diabetes. 1998;106(6):478-83.

PMID:
10079028
8.

Genotypic and phenotypic characterization of six new recombinant congenic strains derived from NOD/Shi and CBA/J genomes.

Reifsnyder PC, Flynn JC, Gavin AL, Simone EA, Sharp JJ, Herberg L, Leiter EH.

Mamm Genome. 1999 Feb;10(2):161-7.

PMID:
9922397
9.

Hyperleptinemia and leptin receptor variant Asp600Asn in the obese, hyperinsulinemic KK mouse strain.

Igel M, Taylor BA, Phillips SJ, Becker W, Herberg L, Joost HG.

J Mol Endocrinol. 1998 Dec;21(3):337-45.

PMID:
9845674
10.

NIDDM genes in mice: deleterious synergism by both parental genomes contributes to diabetogenic thresholds.

Leiter EH, Reifsnyder PC, Flurkey K, Partke HJ, Junger E, Herberg L.

Diabetes. 1998 Aug;47(8):1287-95.

PMID:
9703330
11.

Long-term effects of CCK-agonist and -antagonist on food intake and body weight in Zucker lean and obese rats.

Meereis-Schwanke K, Klonowski-Stumpe H, Herberg L, Niederau C.

Peptides. 1998;19(2):291-9.

PMID:
9493861
12.
13.

Spontaneous epileptiform seizures but increased resistance to kindled seizures in a mutant Sprague-Dawley rat (mf/mf).

Herberg LJ, Rose IC, Davison F, Thom M, Beckett A, Scaravilli F.

Pharmacol Biochem Behav. 1997 Dec;58(4):993-1001.

PMID:
9408205
14.

Hyperleptinemia, leptin resistance, and polymorphic leptin receptor in the New Zealand obese mouse.

Igel M, Becker W, Herberg L, Joost HG.

Endocrinology. 1997 Oct;138(10):4234-9.

PMID:
9322935
15.

CCK-resistance in Zucker obese versus lean rats.

Niederau C, Meereis-Schwanke K, Klonowski-Stumpe H, Herberg L.

Regul Pept. 1997 Jun 18;70(2-3):97-104.

PMID:
9272621
16.
17.

Kindled seizures do not affect adenosinergic inhibition of DA or ACh release in rat accumbens or PFC.

Engelbrecht AH, Russell VA, Mintz M, Lamm MC, Kellaway L, Herberg LJ, Taljaard JJ.

Pharmacol Biochem Behav. 1996 Nov;55(3):315-21.

PMID:
8951971
18.

Long-term and rapid regulation of ob mRNA levels in adipose tissue from normal (Sprague Dawley rats) and obese (db/db mice, fa/fa rats) rodents.

Igel M, Kainulainen H, Brauers A, Becker W, Herberg L, Joost HG.

Diabetologia. 1996 Jul;39(7):758-65.

PMID:
8817099
19.

Nitric oxide synthesis, epileptic seizures and kindling.

Herberg LJ, Grottick A, Rose IC.

Psychopharmacology (Berl). 1995 May;119(1):115-23.

PMID:
7675942
20.

α 2-Adrenoreceptor antagonism may contribute to the atypical properties of risperidone: experimental support for the Nutt case.

Herberg LJ, Montgomery AM, Grottick AJ.

J Psychopharmacol. 1995 Jan;9(3):281-3. doi: 10.1177/026988119500900312.

PMID:
22297769
21.

Impaired FAD-glycerophosphate dehydrogenase activity in islet and liver homogenates of fa/fa rats.

Rasschaert J, Malaisse-Lagae F, Sener A, Leclercq-Meyer V, Herberg L, Malaisse WJ.

Mol Cell Biochem. 1994 Jun 29;135(2):137-41.

PMID:
7838141
22.

Insulin-induced translocation of GLUT 4 in skeletal muscle of insulin-resistant Zucker rats.

Galante P, Maerker E, Scholz R, Rett K, Herberg L, Mosthaf L, Häring HU.

Diabetologia. 1994 Jan;37(1):3-9.

PMID:
8150226
23.
24.

GAD65 is recognized by T-cells, but not by antibodies from NOD-mice.

Bieg S, Seissler J, Herberg L, Northemann W, Scherbaum WA.

Autoimmunity. 1994;17(3):189-94.

PMID:
7948603
25.

FAD-glycerophosphate dehydrogenase activity in pancreatic islets and liver of ob/ob mice.

Sener A, Anak O, Leclercq-Meyer V, Herberg L, Malaisse WJ.

Biochem Mol Biol Int. 1993 Jul;30(3):397-402.

PMID:
8401296
26.

A multiplicity of protein antigens in subcellular fractions of rat insulinoma tissue are able to stimulate T cells obtained from non-obese diabetic mice.

Bieg S, Bailyes EM, Yassin N, Amann J, Herberg L, McGregor AM, Scherbaum WA, Banga JP.

Diabetologia. 1993 May;36(5):385-90.

PMID:
8314441
27.
28.
29.
31.
32.
33.

Interrelationships between obesity and diabetes.

Herberg L.

Proc Nutr Soc. 1991 Dec;50(3):605-18. Review. No abstract available.

PMID:
1809969
34.
35.

5-HT1A agonists and dopamine: the effects of 8-OH-DPAT and buspirone on brain-stimulation reward.

Montgomery AM, Rose IC, Herberg LJ.

J Neural Transm Gen Sect. 1991;83(1-2):139-48.

PMID:
1826841
36.

Persistent MHV (mouse hepatitis virus) infection reduces the incidence of diabetes mellitus in non-obese diabetic mice.

Wilberz S, Partke HJ, Dagnaes-Hansen F, Herberg L.

Diabetologia. 1991 Jan;34(1):2-5.

PMID:
1647335
37.

Excitatory amino acid pathways in brain-stimulation reward.

Herberg LJ, Rose IC.

Behav Brain Res. 1990 Aug 20;39(3):230-9.

PMID:
1978779
39.

The effect of the NMDA receptor antagonist, MK-801, on the course and outcome of kindling.

Mintz M, Rose IC, Herberg LJ.

Pharmacol Biochem Behav. 1990 Apr;35(4):815-21.

PMID:
2161108
40.

Unusual interactions between the neuroleptic haloperidol, and the dopamine D2 partial agonist, terguride.

Stephens DN, Löschmann PA, Lanzinger C, Wachtel H, Montgomery AM, Herberg LJ.

Behav Pharmacol. 1990;1(6):521-529.

PMID:
11175438
43.
44.

Gangliosides in vivo reduce diabetes incidence in non-obese diabetic mice.

Wilberz S, Herberg L, Renold AE.

Diabetologia. 1988 Nov;31(11):855-7.

PMID:
3234640
45.

Chronic l-dopa fails to lessen rebound enhancement of self-stimulation after chronic haloperidol.

Rose IC, Mintz M, Herberg LJ.

Pharmacol Biochem Behav. 1988 Jul;30(3):585-8.

PMID:
3211967
46.
47.

Insulin receptor kinase defects as a possible cause of cellular insulin resistance.

Häring H, Obermaier B, Ermel B, Su Z, Mushack J, Rattenhuber E, Hölzl J, Kirsch D, Machicao F, Herberg L.

Diabete Metab. 1987 Jul;13(3 Pt 2):284-93.

PMID:
2820811
48.

Amygdala kindling modifies interhemispheric dopaminergic asymmetry.

Mintz M, Tomer R, Houpt S, Herberg LJ.

Exp Neurol. 1987 Apr;96(1):137-44.

PMID:
3556506
49.

Effect of pancreatic atrophy and hypertrophy on the small intestine.

Adler G, Hausmann W, Elsebach K, Goke B, Lorenz-Meyer H, Herberg L, Arnold R.

Gut. 1987;28 Suppl:193-5.

50.

Supplemental Content

Loading ...
Support Center